ArticleScientific reports2022
Self-reported visual impairment and sarcopenia among older people in Cameroon.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- Prevalence of sarcopenia in Africa: a systematic review and meta-analysis of observational studies.Aging clinical and experimental research · 2024Pooled it
- Challenges and coping experiences faced by nursing staff in long-term care facilities in China: a qualitative meta-analysis.Frontiers in public health · 2023Pooled it
- Sarcopenia, Depression, Fatigue, and Fear of Falling in Middle-Aged and Older Adults With Visual Impairment: Empirical Research Quantitative.Nursing open · 2026Observational
- The Descriptive Epidemiology of Probable Sarcopenia in Community-Dwelling Tanzanians: A Cross-Sectional Observational Study.Journal of frailty, sarcopenia and falls · 2026Article
- Leveraging interpretable machine learning to identify sarcopenia in middle-aged and older adults with intrinsic capacity decline: an analysis of CHARLS data under AWGS 2025.BMC medical informatics and decision making · 2026Article
- Involvement of best-corrected visual acuity in sarcopenia: findings from baseline analysis of the Kyotango longevity cohort study.Japanese journal of ophthalmology · 2026Article
- Article
- Prevalence of intrinsic capacity impairment and associated factors among retired older people in Cameroon.BMC geriatrics · 2025Article
- Age and gender differences in health characteristics of older people with visual impairment.Aging clinical and experimental research · 2025Article
- Article
- Pre-Therapeutic Assessment of Older People in Sub-Saharan Africa: Introduction to the Comprehensive Geriatric Assessment.Journal of clinical medicine · 2024Review
- A Critical Review of Current Worldwide Definitions of Sarcopenia.Calcified tissue international · 2024Review
- Short Physical Performance Battery and Study of Osteoporotic Fractures Index in the Exploration of Frailty Among Older People in Cameroon.International journal of public health · 2023Article
- Factors Associated with Cognitive Impairment among Adults of 55 Years and Older in Cameroon.Dementia and geriatric cognitive disorders extraArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging has been clearly associated with decline in visual and physical performance. Alteration of visual function is associated with negative health outcomes including physical frailty. We assessed the relationship between Visual Impairment (VI) and sarcopenia in older persons in Cameroon. In a cross-sectional survey conducted in Douala in 2019, sarcopenia was assessed using the SPPB (Short Physical Performance Battery) test scored from 0 to 12. The diagnosis of sarcopenia was based on SPPB test score < 9 while VI was self-reported. Of the 403 participants (50.4% male) with a mean age of 67.1 (± 6.2) years, 356 (88.3%) reported a VI while the prevalence of sarcopenia was 47.9% [95% CI 43.0-52.7]. After adjusting for several factors, VI was significantly associated with sarcopenia (OR 2.66 [95% CI 1.29-5.48]). Of the SPPB subtests, only chair stand test was negatively associated with VI (β = - 0.45 [95% CI - 0.82 to 0.07]). Our study supports an association between VI and sarcopenia. If confirmed by further cohort studies, this result would suggest that VI could be considered as an early indicator of sarcopenia among older people in sub-Saharan Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.